Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
The original article [1] contains an error in the y-axes of Fig. 8’s sub-figures whereby ‘CSF’ is mistakenly mentioned instead of ‘serum’.
Main Authors: | Mylene Huebecker, Elizabeth B. Moloney, Aarnoud C. van der Spoel, David A. Priestman, Ole Isacson, Penelope J. Hallett, Frances M. Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Molecular Neurodegeneration |
Online Access: | https://doi.org/10.1186/s13024-019-0355-z |
Similar Items
-
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01) -
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Huebecker, M, et al.
Published: (2019) -
Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
by: Somogyi, A, et al.
Published: (2018) -
Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain
by: Hallett, PJ, et al.
Published: (2018) -
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
by: Oeystein R. Brekk, et al.
Published: (2020-08-01)